Best Small Cap Stocks To Watch Today - April 23rd

Key Points

• Inflection Point Acquisition Corp. II (IPXX), Spring Valley Acquisition (SV) and Predictive Oncology (POAI) were flagged by MarketBeat's screener as the top Small Cap stocks to watch today after posting the highest dollar trading volume among small caps in recent days.
• Predictive Oncology (POAI) is a science-driven oncology drug-discovery company that pairs machine learning with a biobank of roughly 150,000 tumor samples to accelerate advancing molecules into medicine.
• Small-cap stocks can offer higher growth potential but typically come with greater volatility, lower liquidity and higher business risk versus mid- and large-cap companies, so investors should consider the risk profile before investing.

Inflection Point Acquisition Corp. II, Spring Valley Acquisition, and Predictive Oncology are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of publicly traded companies with relatively small market capitalizations—commonly defined as roughly $300 million to $2 billion, though exact cutoffs vary by index and provider. Market capitalization is calculated by multiplying the current share price by the number of outstanding shares. For investors, small caps often offer higher growth potential but also greater volatility, lower liquidity, and higher business risk compared with mid- and large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Inflection Point Acquisition Corp. II (IPXX)

Read Our Latest Research Report on IPXX

Spring Valley Acquisition (SV)

Read Our Latest Research Report on SV

Predictive Oncology (POAI)

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.

Read Our Latest Research Report on POAI

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.